Clinical Trial Update: Pharmacokinetics, Pharmacodynamics, and Safety Study of Ticagrelor in Hemodialysis Patients and Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics, pharmacodynamics, and safety study of ticagrelor in hemodialysis patients and healthy subjects completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Failure Chronic

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: AstraZeneca | Conditions: Kidney Failure, Chronic | Phase 1 | Status: COMPLETED | Results posted: 2017-09-29